Nxstage Medical, Inc.: FDA filings under this applicant name
FDA lists 51 510(k) clearances under the applicant name “Nxstage Medical, Inc.” (first 2001, latest 2024), across 12 product codes in 2 review panels. Median 510(k) review time under this name: 108 days. Since 2017 the median was 112 days, against 205 days for all cleared 510(k)s in the same product codes. Related companies, subsidiaries and acquired businesses that file under other applicant names are counted on their own pages, not here.
Caduvo groups this applicant name under Fresenius Medical Care, based on public ownership records.
510(k) clearances per year
| Year | Clearances | Median review days |
|---|---|---|
| 2012 | 1 | 437 |
| 2013 | 5 | 139 |
| 2014 | 7 | 104 |
| 2015 | 2 | 111 |
| 2016 | 0 | — |
| 2017 | 2 | 95 |
| 2018 | 1 | 62 |
| 2019 | 1 | 267 |
| 2020 | 0 | — |
| 2021 | 0 | — |
| 2022 | 0 | — |
| 2023 | 1 | 157 |
| 2024 | 2 | 148 |
| 2025 | 0 | — |
| 2026 | 0 | — |
Review time against the same product codes
Since 2017, 510(k)s cleared under the name Nxstage Medical, Inc. took a median 112 days from FDA receipt to decision. All cleared 510(k)s in the same product codes over the same years took a median 205 days.
Top product codes
| Product code | Device | Submissions | 510(k) clearances |
|---|---|---|---|
| KDI | Dialyzer, High Permeability With Or Without Sealed Dialysate System | 26 | 26 |
| KPO | Dialysate Concentrate For Hemodialysis (Liquid Or Powder) | 6 | 6 |
| FKR | Subsystem, Proportioning | 5 | 5 |
| FKP | System, Dialysate Delivery, Single Patient | 4 | 4 |
| FJK | Set, Tubing, Blood, With And Without Anti-Regurgitation Valve | 2 | 2 |
| ODN | Ultrafiltration-Controlled Nocturnal Dialysate Delivery System | 2 | 2 |
| FIE | Needle, Fistula | 1 | 1 |
| FII | System, Dialysate Delivery, Sealed | 1 | 1 |
| FIP | Subsystem, Water Purification | 1 | 1 |
| FLA | Monitor, Temperature, Dialysis | 1 | 1 |
Plus 2 more product codes.
Review panels
Most recent Nxstage Medical, Inc. 510(k) clearances
| 510(k) | Device | Product code | Decision date | Review days |
|---|---|---|---|---|
| K232803 | NxStage System One with Cartridge Express (CAR-170-E and CAR-172-E) | KDI | 2024-03-14 | 184 |
| K233213 | NxStage PureFlow Solution | KPO | 2024-01-18 | 112 |
| K230632 | VersiHD with GuideMe software | KDI | 2023-08-11 | 157 |
| K183158 | NxStage Cartridge Express with Speedswap | KDI | 2019-08-09 | 267 |
| K181991 | NxStage Connected Health System | FKP | 2018-09-26 | 62 |
| K171331 | NxStage System One | KDI | 2017-08-24 | 108 |
| K170469 | NxStage System One Plus | KDI | 2017-05-09 | 82 |
| K150472 | NxStage System One | ODN | 2015-06-04 | 101 |
| K143313 | NxStage Therapeutic Plasma Exchange (TPE) Cartridge | KDI | 2015-03-20 | 121 |
| K141752 | NXSTAGE SYSTEM ONE | ODN | 2014-12-19 | 172 |
41 earlier clearances. See the full list in Caduvo.
Recalls
36 product recalls in 16 recall events; 2 initiated in the last five years. Most recent: 2025-04-28.
15 product recalls in 4 recall events filed under other recalling-firm names cite a 510(k) or PMA held under this applicant name; 15 initiated in the last five years. Most often: B Braun Medical Inc (13), B BRAUN MEDICAL INC (1), NxStage MDS Corporation (1).
These recall records list the clearance number, so the device was cleared under this name. The recalling firm may be the same company under another spelling, a company that acquired the product line, a relabeler or a contract manufacturer. They are not added to the count above.
Recalling firms are matched to this applicant name by name only (same normalization), so related entities that recall under another name are not counted. A recall count says nothing about how safe one company's devices are compared with another's.
Parent company SEC filings
Fresenius Medical Care AG (FMCQF, FMS): EDGAR filings, CIK 1333141. Caduvo groups Nxstage Medical, Inc. under Fresenius Medical Care; the parent's SEC registrant is entered by hand for the group, not matched by name.
Frequently asked questions
How many FDA 510(k) clearances are listed under Nxstage Medical, Inc.?
FDA lists 51 510(k) clearances under the applicant name “Nxstage Medical, Inc.” (first 2001, latest 2024), across 12 product codes in 2 review panels. Filings under other applicant names, such as subsidiaries, are not included.
How long has FDA taken to clear 510(k)s filed by Nxstage Medical, Inc.?
The median time from FDA receipt to decision across 510(k)s cleared under the name Nxstage Medical, Inc. is 108 days. Since 2017: 112 days, versus 205 days for all cleared 510(k)s in the same product codes.
Which FDA product codes appear under Nxstage Medical, Inc.?
The most frequent FDA product codes under this applicant name are KDI (Dialyzer, High Permeability With Or Without Sealed Dialysate System, 26); KPO (Dialysate Concentrate For Hemodialysis (Liquid Or Powder), 6); FKR (Subsystem, Proportioning, 5).
Next steps
- See all 51 Nxstage Medical, Inc. clearances with predicates and recalls
- Run predicate analysis for product code KDI, Nxstage Medical, Inc.'s most frequent
Compiled by Caduvo from public U.S. government records. Counts cover filings under the applicant name shown on this page only. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA or any other agency, or by the companies named. Not regulatory advice. Report an error in this data. Data and corrections policy.